Japan's lack of lag nearly in the bag and worth a brag
This article was originally published in Scrip
Executive Summary
Japan's regulatory authorities continue to take various steps to improve approval procedures for pharmaceuticals and have now essentially eliminated the much criticised "drug lag" characteristic of the system just a few years ago. Efforts to resolve the remaining delays will now be down largely to applicants' efforts, one senior official has suggested.